Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trialSaul N. Faust, DV Dung, Christine E. Jones et al.|The Lancet Child & Adolescent Health|2024Cited by 38